Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...

Two bills heard in a state Senate committee are designed to lower prices, provide fair competition for independent pharmacies ...

The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...

President Joe Biden signed Executive Order 14087, a measure designed to lower the cost of prescription drugs for Americans.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

With the Trump administration taking over and reversing this Biden-era policy, could we see an increase prescription drug ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

We are being reimbursed below our cost. So, you can imagine, right now, we’re operating on fumes,” said Anna Peoples of ...